Insider Transactions in Q1 2024 at Rezolute, Inc. (RZLT)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 28
2024
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
500
+31.73%
|
$1,000
$2.55 P/Share
|
Mar 15
2024
|
Daron Evans CFO |
BUY
Open market or private purchase
|
Indirect |
20,000
+50.0%
|
$20,000
$1.69 P/Share
|
Mar 14
2024
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$10,000
$1.88 P/Share
|
Mar 08
2024
|
Daron Evans CFO |
BUY
Open market or private purchase
|
Direct |
50,000
+29.26%
|
$50,000
$1.93 P/Share
|
Mar 07
2024
|
Young Jin Kim |
BUY
Open market or private purchase
|
Direct |
36,503
+24.02%
|
$36,503
$1.91 P/Share
|
Mar 07
2024
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
500
+50.0%
|
$500
$1.85 P/Share
|
Feb 26
2024
|
Nevan C Elam CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+39.01%
|
$5,000
$1.68 P/Share
|
Feb 26
2024
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+4.49%
|
$2,000
$1.7 P/Share
|
Feb 23
2024
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+12.89%
|
$6,000
$1.69 P/Share
|
Feb 16
2024
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+16.85%
|
$7,000
$1.31 P/Share
|
Feb 16
2024
|
Daron Evans CFO |
BUY
Open market or private purchase
|
Indirect |
9,000
+50.0%
|
$9,000
$1.37 P/Share
|
Feb 16
2024
|
Daron Evans CFO |
BUY
Open market or private purchase
|
Direct |
41,900
+37.15%
|
$41,900
$1.3 P/Share
|